Differential coexpression of mex efflux pumps in a clinical strain of metallo-β-lactamase-producing pseudomonas aeruginosa during the stepwise evolution of resistance to aminoglycosides

Infectious Diseases in Clinical Practice

Volumn 19, Issue 1, 2011, Pages 38-42

  Asai, Satomi ^a   Ohshima, Toshio ^b   Yoshihara, Eisaku ^c   Jin, Guilan ^a   Umezawa, Kazuo ^a   Inokuchi, Sadaki ^a   Miyachi, Hayato ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

^c Jikei University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE; GENTAMICIN; METALLO BETA LACTAMASE; PROTEIN MEXA; PROTEIN MEXE; PROTEIN MEXX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BURN; GENE EXPRESSION; GENE SEQUENCE; IMMUNODETECTION; INJURY SEVERITY; ISOLATION PROCEDURE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION; WESTERN BLOTTING;

EID: 78651425191     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3181f69a24     Document Type: Article

References (22)

1. Tredget EE, Shankowsky HA, Rennie R, et al. Pseudomonas infections in the thermally injured patient. Burns. 2004;30:3-26. (Pubitemid 38029120)
2. Mese S, Nergiz S, Gul K, et al. Microorganisms isolated from burn wounds and their antibiotic susceptibility. J Burn Care Res. 2008;29:1018.
3. Kirikae T, Mizuguchi Y, Arakawa Y. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother. 2008;61:612-615. (Pubitemid 351321135)
4. Harris A, Torres-Viera C, Venkataraman L, et al. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis. 1999;28:1128-1133. (Pubitemid 29203551)
5. Li X-Z, Nikaido H. Efflux-mediated drug resistance in bacteria. Drug. 2004;64:159-204. (Pubitemid 38186964)
6. Sekiguchi JI, Asagi T, Miyoshi-Akiyama T, et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol. 2007;45:979-989. (Pubitemid 46427721)
7. Henrichfreise B, Wiegand I, Pfister W, et al. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother. 2007;51:4062-4070. (Pubitemid 350057805)
8. Mesaros N, Glupczynski Y, Avrain L, et al. A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa. J Antimicrob Chemother. 2007;59:378-386. (Pubitemid 47073443)
9. Masuda N, Sakagawa E, Ohya S, et al. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:2242-2246. (Pubitemid 30650862)
10. Masuda N, Sakagawa E, Ohya S, et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3322-3327. (Pubitemid 33009490)
11. Lee A, Mao W, Warren MS, et al. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol. 2000;182:3142-3150. (Pubitemid 30326929)
12. Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 16th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006. Informational supplement M100-S16.
13. Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol. 2000;38:40-43. (Pubitemid 30043261)
14. Dawson SL, Fry JC, Dancer BN. A comparative evaluation of five typing techniques for determining the diversity of fluorescent pseudomonads. J Microbiol Methods. 2002;50:9-22.
15. Syrmis MW, O'Carroll MR, Sloots TP, et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-elementYbased PCR assays. J Med Microbiol. 2004;53:1089-1096.
16. Grundmann H, Schneider C, Hartung D, et al. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol. 1995;33:528-534.
17. Li XZ, Barre N, Pool K. Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother. 2000;46:885-893. (Pubitemid 32000597)
18. Maseda H, Yoneyama H, Nakae T. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:658-664. (Pubitemid 30117958)
19. Yoneyama H, Ocaktan A, Gotoh N, et al. Subunit swapping in the Mex-extrusion pumps in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1998;244:898-902. (Pubitemid 28418167)
20. Llanes C, Hocquet D, Vogne C, et al. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXYefflux pumps simultaneously. Antimicrob Agents Chemother. 2004;48:1797-1802. (Pubitemid 38544391)
21. Vogne C, Ramos Aires J, Bailly C, et al. Role of multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2004;48:1676-1680. (Pubitemid 38544374)
22. Hocquet D, Vogne C, El Garch F, et al. MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 2003;47:1371-1375. (Pubitemid 36368599)